What to Do When Your Specialty Pharmacy Delays Your Biologic

Your injection is due in four days, the specialty pharmacy said the shipment went out, and tracking shows nothing. Each call produces a slightly different explanation, nobody commits to a ship date, and the dose date gets closer. Maintenance biologics used in inflammatory bowel disease run on fixed intervals, so a shipment that slips by two weeks is a real gap in therapy. What follows is a concrete escalation path, the questions that move a stalled order, and the record you should build while you make the calls.

Find out which link in the chain is stuck

A specialty pharmacy delay is rarely one problem. Three separate parties can hold up a shipment: the prescriber, whose office may owe a renewed prescription or clinical notes; the health plan or pharmacy benefit manager, which may have an expired prior authorization or a pending appeal; and the pharmacy itself, which may be waiting on copay assistance enrollment, a benefits re-verification, refrigerated shipping capacity, or a returned delivery. Ask the pharmacy directly which of the three it is waiting on and what specifically is outstanding. Prior authorization sits at the center of most of these holds, and a systematic review of specialty drug utilization management found prior authorization alone produced treatment delays ranging from about 3.6 days for cancer drugs up to 31 days for rheumatoid arthritis and inflammatory bowel disease biologics. Knowing which party owns the delay tells you who to call next.

Know what a typical delay looks like

Delays of this kind are well documented in IBD. A single-center study of biologic dose escalation found a median of 7 days from the decision to escalate to insurance approval, rising to a median of 29 days when an appeal was required, and patients with longer approval times were less likely to show improvement in C-reactive protein. A five-year chart review at a university gastroenterology clinic reported an average time to approval of 30.5 days and an average time to first infusion of 45.3 days, with longer waits for patients on Medicaid and Medicare. In pediatric IBD, a national provider survey found a median delay of 18 days to receive the prescribed medication, with 60% of patients experiencing an adverse outcome or worsened quality of life and 21% hospitalized. That survey also found 77% of initial denials were eventually approved, which is the argument for escalating rather than waiting.

Make the first call count, and write everything down

Open the call by giving your name, date of birth, prescription number, and the exact date your next dose is due, then ask four things: what is the current status of the order, what is holding it, what is the committed ship date, and what is the case or reference number for this call. Get the representative's first name and the time, repeat the commitment back, and ask them to note it in the file. Then log the call in a running incident record with the date, who you spoke to, the case number, what was promised, and the deadline it created. That log lets you say on the next call that a named representative promised a ship date three days ago, which turns a fresh request into a broken commitment. It is also the evidence base for any later complaint or appeal.

Escalate when nobody commits to a ship date

If two calls produce no firm ship date, stop repeating the first-line request. Ask directly for a supervisor or for the pharmacy's patient advocate or case manager, and ask that the order be flagged as a therapy interruption risk because a scheduled maintenance dose is at stake. In parallel, ask the nurse or clinical pharmacist at your prescriber's office to call the specialty pharmacy on a peer line, which usually reaches a different queue than the patient line. Send the office your incident log so they are not starting from zero. If the hold is on the plan side rather than the pharmacy side, the prescriber is the party who can request an expedited coverage decision, and under Medicare Part D a plan that approves an expedited request must decide no later than 24 hours after receiving it.

Ask about a bridge supply and an expedited decision

While the underlying problem is being resolved, ask two specific questions. Ask the pharmacy whether a bridge or emergency supply is available, either through the plan's transition fill policy or through the manufacturer's patient support program, which often provides free product during a coverage lapse. Ask the plan whether the request can be expedited. CMS requires Part D plans to decide initial coverage determinations within 24 hours of an expedited request or 72 hours of a standard request, and Medicare's appeals process runs five levels, so a denial at the first stage is not the end of the road. For commercial coverage, an internal appeal that fails can go to independent external review, which must be decided within 45 days for standard requests and within 72 hours when expedited.

Handle the dose date itself

Ask your gastroenterology team what to do about the dose you will miss rather than deciding on your own, and give them the date of your last dose. Intervals matter because they are part of the approved regimen: Entyvio maintenance is 300 mg intravenously every eight weeks or 108 mg subcutaneously every two weeks, and Stelara maintenance is 90 mg subcutaneously every eight weeks. Interrupted, episodic dosing of biologics is associated with a higher rate of anti-drug antibody formation and a greater risk of reactions on re-treatment after a break than continuous scheduled maintenance, which is why a gap is worth documenting in your chart even if you feel well. Record the missed date, the reason, and any symptom change in the same log you have been keeping.

Use the regulators when the pharmacy stops responding

If the pharmacy will not give a status or a supervisor, two external channels apply. State boards of pharmacy license and investigate the dispensing pharmacy, and contact information for every board is available through the National Association of Boards of Pharmacy directory. Insurance conduct, including plan-side authorization holds, falls to your state insurance department, and the National Association of Insurance Commissioners maintains a directory for filing consumer complaints. A complaint filed with dates, case numbers, and named representatives is treated differently from a general account of poor service, which is the reason to keep the log from the first call rather than reconstructing it later. Most of these delays do resolve, and they resolve fastest for patients who can show exactly what was promised and when.